A comprehensive view of eli lilly & co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "COMPOSITIONS OF EXTENDED RELEASE COATINGS AND METHODS FOR APPLYING EXTENDED RELEASE COATINGS"
Published: February 01, 2023 by U.S. Fed News
US Patent Issued to Eli Lilly and Co. on Jan. 31 for "Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer" (Indiana Inventors)
Published: February 01, 2023 by U.S. Fed News
Darryle D. Schoepp, Ph.D., former Merck and Eli Lilly executive, joins Scientific Advisory Board of Akelos Inc., a biotechnology company developing opioid alternatives; Dr. Schoepp recently retired from Merck after 30 years in the pharmaceutical industry
Published: February 01, 2023 by Newswire.com
Eli Lilly and Company Seeks Patent for Novel RNA Therapeutics and Uses Thereof
Published: January 30, 2023 by Biotechnology Patent News
Eli Lilly and Company Submits Patent Application for CD73 Inhibitors
Published: January 27, 2023 by Pharmaceutical Patent News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count